Alzamend Neuro, Inc. (ALZN): Total Assets
$2.08M
As of 2026-04-30
$8.54M
As of 2026-07-31
-29.4%
3-year compound annual growth
-6.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-04-30 | $2.08M | -54.8% | 2026-07-22, Balance as of period end |
| 2025-04-30 | $4.60M | +628.8% | 2026-07-22, Balance as of period end |
| 2024-04-30 | $631.6K | -89.3% | 2025-07-22, Balance as of period end |
| 2023-04-30 | $5.92M | -59.2% | 2024-07-30, Balance as of period end |
| 2022-04-30 | $14.52M | +398.4% | 2023-07-27, Balance as of period end |
| 2021-04-30 | $2.91M | +60.6% | 2022-07-19, Balance as of period end |
| 2020-04-30 | $1.81M | n/a | 2021-07-29, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | 2026-04-30 | $2.08M | -54.8% |
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | $2.51M | -55.9% |
| Accustem Sciences Inc. (ACUT) | 2025-12-31 | $1.55M | n/m |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | $2.80M | -40.4% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.81M | -49.4% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $2.93M | +9.7% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.97M | +7.7% |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | $3.03M | -80.6% |
Compare ALZN, INTI, ACUT, ARTL side by side · Screen every company in Pharmaceutical Preparations ↗